Opko Health
OPK
239 hedge funds and large institutions have $817M invested in Opko Health in 2021 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 83 increasing their positions, 63 reducing their positions, and 39 closing their positions.
68% more call options, than puts
Call options by funds: $21.9M | Put options by funds: $13M
32% more repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 63
10% more capital invested
Capital invested by funds: $742M → $817M (+$74.8M)
8% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 39
0.39% more ownership
Funds ownership: 28.05% → 28.43% (+0.39%)
0% more funds holding
Funds holding: 239 → 239 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$16.7M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$8.5M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.3M |
| 4 |
BlackRock
New York
|
+$5.23M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$17M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$8M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$7.97M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.43M |
| 5 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$3.67M |
OPK Hedge Fund Activity: Q1 2021 in Review
239 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Opko Health (OPK) for Q1 2021, worth a combined $817M — up 10% from $742M a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new OPK positions and 39 closed out — a net gain of 3 holders — while 83 added to existing stakes and 63 trimmed.
The largest buyer was D.E. Shaw & Co, adding an estimated $16.7M. The largest seller was State Street, cutting an estimated $17M.
- 239 institutional investors held Opko Health (OPK) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $817M of Opko Health stock for Q1 2021, up 10% quarter-over-quarter.
- 42 funds opened new Opko Health positions in Q1 2021 and 39 closed out, a net change of +3 holders.
- The largest Opko Health buyer in Q1 2021 was D.E. Shaw & Co, an estimated $16.7M added.
- The largest Opko Health seller in Q1 2021 was State Street, an estimated $17M sold.
Based on aggregated 13F filings for Q1 2021.